Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP296215.RAbOrXP9ZVz4SpngTz8Ucp0F9smBYJH3IIBz-Quy3pYj8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP296215.RAbOrXP9ZVz4SpngTz8Ucp0F9smBYJH3IIBz-Quy3pYj8130_assertion type Assertion NP296215.RAbOrXP9ZVz4SpngTz8Ucp0F9smBYJH3IIBz-Quy3pYj8130_head.
- NP296215.RAbOrXP9ZVz4SpngTz8Ucp0F9smBYJH3IIBz-Quy3pYj8130_assertion description "[To explore the potential for monoclonal antibodies as a treatment for immune thrombocytopenia (ITP) and to further explore their mechanisms of action, we tested 8 monoclonal CD44 antibodies in murine ITP and found 4 antibodies that could successfully ameliorate ITP; 2 of these antibodies function at a full 3-log fold lower dosage compared with IVIg.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP296215.RAbOrXP9ZVz4SpngTz8Ucp0F9smBYJH3IIBz-Quy3pYj8130_provenance.
- NP296215.RAbOrXP9ZVz4SpngTz8Ucp0F9smBYJH3IIBz-Quy3pYj8130_assertion evidence source_evidence_literature NP296215.RAbOrXP9ZVz4SpngTz8Ucp0F9smBYJH3IIBz-Quy3pYj8130_provenance.
- NP296215.RAbOrXP9ZVz4SpngTz8Ucp0F9smBYJH3IIBz-Quy3pYj8130_assertion SIO_000772 21045192 NP296215.RAbOrXP9ZVz4SpngTz8Ucp0F9smBYJH3IIBz-Quy3pYj8130_provenance.
- NP296215.RAbOrXP9ZVz4SpngTz8Ucp0F9smBYJH3IIBz-Quy3pYj8130_assertion wasDerivedFrom befree-20150227 NP296215.RAbOrXP9ZVz4SpngTz8Ucp0F9smBYJH3IIBz-Quy3pYj8130_provenance.
- NP296215.RAbOrXP9ZVz4SpngTz8Ucp0F9smBYJH3IIBz-Quy3pYj8130_assertion wasGeneratedBy ECO_0000203 NP296215.RAbOrXP9ZVz4SpngTz8Ucp0F9smBYJH3IIBz-Quy3pYj8130_provenance.